Picard Frauke, Panagiotidou Petroula, Wolf-Pütz Ana, Buschmann Ivo, Buschmann Eva, Steffen Maximilian, Klein Rolf Michael
Department of Cardiology, Augusta Hospital Düsseldorf, Academic Teaching Hospital of the University Faculty of Health, Düsseldorf, Germany.
Department of Cardiology, Augusta Hospital Düsseldorf, Academic Teaching Hospital of the University Faculty of Health, Düsseldorf, Germany.
Am J Cardiol. 2018 Feb 15;121(4):416-422. doi: 10.1016/j.amjcard.2017.11.004. Epub 2017 Nov 24.
The aim of this study was to elucidate if patients with coronary artery disease (CAD), who fail to respond to revascularization procedures, can improve from individual shear rate therapy (ISRT). The ISRT is an adaptation of the external counterpulsation with lower individual treatment pressures based on Doppler-ultrasound measurements during counterpulsation. In contrast to the external counterpulsation therapy, the ISRT is based on the detection of the individual intra-arterial shear rate. Here we report about the first clinical trial of 31 patients with CAD who were enrolled for 30 sessions of ISRT. To determine the therapeutic effect of ISRT we measured the exercise capacity, the arterial stiffness, the aortic wave reflection, and the 24-hour blood pressure before and after 30 treatment sessions. After 6 weeks of accomplished ISRT the walking distance during the 6-minute walking test extended by 78 m (p = 0.007). The total exercise duration in the exercise stress electrocardiogram increased by 84 seconds (p = 0.012) but not the stress intensity (p = 0.086). The pulse wave velocity decreased by 1.2 m/s (p = 0.004) and demonstrated a decrease in arterial stiffness. Pulse wave analysis results demonstrated a progressive decrease in central blood pressure by 12 mmHg (p = 0.008), in pulse pressure by 9 mmHg (p = 0.005), and in augmentation pressure by 5.3 mmHg (p = 0.004). The 24-hour blood pressure decreased systolic by 15 mmHg (p <0.001) and diastolic by 8 mmHg (p = 0.033). The patients also benefited subjectively followed by New York Heart Association and Canadian Cardiovascular Society classifications. In conclusion, the ISRT is an effective treatment for patients with CAD to improve cardiac fitness, arterial stiffness, and to reduce blood pressure.
本研究的目的是阐明冠状动脉疾病(CAD)患者在血运重建手术中无反应者是否能从个体化剪切率疗法(ISRT)中获益。ISRT是一种基于反搏期间多普勒超声测量结果、采用较低个体化治疗压力的体外反搏改良疗法。与体外反搏疗法不同,ISRT基于个体动脉内剪切率的检测。在此,我们报告了一项针对31例CAD患者的首次临床试验,这些患者接受了30次ISRT治疗。为确定ISRT的治疗效果,我们在30次治疗前后测量了运动能力、动脉僵硬度、主动脉波反射和24小时血压。在完成6周的ISRT治疗后,6分钟步行试验中的步行距离延长了78米(p = 0.007)。运动应激心电图中的总运动持续时间增加了84秒(p = 0.012),但应激强度未增加(p = 0.086)。脉搏波速度降低了1.2米/秒(p = 0.004),表明动脉僵硬度降低。脉搏波分析结果显示中心血压逐渐降低12毫米汞柱(p = 0.008),脉压降低9毫米汞柱(p = 0.005),增压压力降低5.3毫米汞柱(p = 0.004)。24小时血压收缩压降低15毫米汞柱(p <0.001),舒张压降低8毫米汞柱(p = 0.033)。患者在纽约心脏协会和加拿大心血管学会分类方面也有主观改善。总之,ISRT是一种治疗CAD患者以改善心脏适应性、降低动脉僵硬度和降低血压的有效疗法。